Yang ZANG
Inventor
Stats
- 0 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 7 US Applications Filed
- 2 Total Citation Count
- Mar 28, 2023 Most Recent Filing
- Jan 22, 2020 Earliest Filing
Work History
No Work History Available.Inventor Addresses
Address | Duration |
---|---|
Hubei, CN | Jun 30, 22 - Feb 11, 25 |
Wuhan, CN | Jul 20, 23 - Jul 20, 23 |
Wuhan, Hubei, CN | Mar 03, 22 - Apr 10, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
B01J: | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0115,613 | 2025 | DIARYL COMPOUND AS TUBULIN/SRC DUAL TARGET INHIBITOR | 0 |
12221449 | 2025 | Pyrrolopyrimidine derivative and use thereof | 0 |
2024/0368,088 | 2024 | EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH AND USE THEREOF | 0 |
2024/0287,064 | 2024 | TRICYCLIC COMPOUND USED AS GPR84 ANTAGONIST | 0 |
2023/0227,445 | 2023 | BENZAMIDE COMPOUND AND USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.